Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2

European Journal of Pharmacology

Volumn 573, Issue 1-3, 2007, Pages 11-19

  Castelli, M Paola ^a   Paola Piras, A ^a   D'Agostino, Antonella ^b   Pibiri, Fabio ^a   Perra, Simona ^a   Gessa, Gian Luigi ^a   Maccarrone, Mauro ^b,c   Pistis, Marco ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF TERAMO   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

3H CP 55,940 binding; Anandamide; Cannabinoid CB1 receptor; Endocannabinoid; FAAH; GTP S binding; NAPE PLD; Prenatal

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABIS; FATTY ACID AMIDASE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); N ACYLPHOSPHATIDYLETHANOLAMINE SPECIFIC PHOSPHOLIPASE D; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN DEVELOPMENT; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; DRUG RECEPTOR BINDING; EMOTION; ENZYME ACTIVITY; FEMALE; FETUS; HIPPOCAMPUS; LEARNING; LIMBIC CORTEX; MALE; MEMORY; MOTOR ACTIVITY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BENZOXAZINES; BINDING, COMPETITIVE; BRAIN; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); LITTER SIZE; MALE; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; PHOSPHOLIPASE D; POLYUNSATURATED ALKAMIDES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID; SULFUR RADIOISOTOPES; WEIGHT GAIN;

EID: 34648857609     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.047     Document Type: Article

References (58)

1. Adams I.B., Ryan W., Singer M., Thomas B.F., Compton D.R., Razdan R.K., and Martin B.R. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273 (1995) 1172-1181
2. Antonelli T., Tanganelli S., Tomasini M.C., Finetti S., Trabace L., Steardo L., Sabino V., Carratu M.R., Cuomo V., and Ferraro L. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat. Neuroscience 124 (2004) 367-375
3. Antonelli T., Tomasini M.C., Tattoli M., Cassano T., Tanganelli S., Finetti S., Mazzoni E., Trabace L., Steardo L., Cuomo V., and Ferraro L. Prenatal exposure to the CB1 receptor agonist causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring Cereb. Cortex 15 (2005) 2013-2020
4. Ameri A. The effects of cannabinoids on the brain. Prog. Neurobiol. 58 (1999) 315-348
5. Ashton C.H. Pharmacology and effects of cannabis: a brief review. Br. J. Psychiatry 178 (2001) 101-106
6. Berrendero F., Garcia-Gil L., Hernandez M.L., Romero J., Cebeira M., de Miguel R., Ramos J.A., and Fernandez Ruiz J.J. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 125 (1998) 3179-3188
7. Biegon A., and Kerman I.A. Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. Neuroimage 14 (2001) 1463-1468
8. Bonnin A., de Miguel R., Rodriguez-Manzaneque J.C., Fernandez-Ruiz J.J., Santos A., and Ramos J.A. Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Dev. Brain Res. 81 (1994) 147-150
9. Bonnin A., de Miguel R., Hernandez M.L., Ramos J.A., and Fernandez-Ruiz J.J. The prenatal exposure to Δ9-9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 56 (1995) 2177-2184
10. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Breivogel C.S., Sim L.J., and Childers S.R. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282 (1997) 1632-1642
12. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., and Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265 (1993) 218-226
13. Dalterio S.L. Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice. Pharmacol. Biochem. Behav. 12 (1980) 143-153
14. Dalterio S.L. Cannabinoid exposure: effects on development. Neurobehav. Toxicol. Teratol. 8 (1986) 345-352
15. Dalterio S.L., and Bartke A. Perinatal exposure to cannabinoids alter male reproductive function in mice. Science 205 (1979) 420-422
16. Davies S.N., Pertwee R.G., and Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42 (2002) 993-1007
17. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
18. Ebrahim S.H., and Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet. Gynecol. 101 (2003) 374-379
19. Fernandez-Ruiz J.J., Berrendero F., Hernàndez M.L., Romero J., and Ramos J.A. Role of endocannabinoids in brain development. Life Sci. 65 (1999) 725-736
20. Fernandez-Ruiz J.J., Berrendero F., Hernàndez M.L., and Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23 (2000) 14-20
21. Fezza F., Gasperi V., Mazzei C., and Maccarrone M. Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD) activity. Anal. Biochem. 339 (2005) 113-120
22. Fride E. The endocannabinoid-CB(1) receptor system in pre- and postnatal life. Eur. J. Pharmacol. 500 (2004) 289-297
23. Fried P.A., and Smith A.M. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol. Teratol. 23 (2001) 1-11
24. Fried P.A., Watkinson B., and Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol. Teratol. 25 (2003) 427-436
25. 9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicol. Teratol. 20 (1998) 549-553
26. A, receptor agonists in adult rats. Neurotoxicol. Teratol. 21 (1999) 277-283
27. 9-tetrahydrocannabinol. Drug alcohol Depend. 55 (1999) 127-136
28. Gerdeman G.L., Ronesi J., and Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5 (2002) 446-451
29. Gerdeman G.L., Partridge J.G., Lupica C.R., and Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26 (2003) 184-192
30. Glowinski J., and Iversen L.L. Catecholamine regional metabolism in rat brain. J. Neurochem. 13 (1966) 655-669
31. Hampson R.E., and Deadwyler S.A. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J. Neurosci. 20 (2000) 8932-8942
32. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
33. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
34. Hutchings D.E., Martin B.R., Gamagaris Z., Miller N., and Fico T. Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44 (1989) 697-701
35. Leech S.L., Richardson G.A., Goldschmidt L., and Day N.L. Prenatal substance exposure: effects on attention and impulsivity of 6-years-olds. Neurotoxicol. Teratol. 21 (1999) 109-118
36. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol. Biochem. Behav. 81 (2005) 319-330
37. Maccarrone M., and Wenger T. Effects of cannabinoids on hypothalamic and reproductive function. Handb Exp. Pharmacol. 168 (2005) 540-556
38. Maccarrone M., Attinà M., Bari M., Cartoni A., Ledent C., and Finazzi-Agrò A. Anandamide degradation and N-acylethanolamines level in wild type and CB1 cannabinoid receptor knockout mice of different ages. J. Neurochem. 78 (2001) 339-348
39. Maccarrone M., Barboni B., Paradisi A., Bernabò N., Gasperi V., Pistilli M.G., Fezza F., Lucidi P., and Mattioli M. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J. Cell Sci. 118 (2005) 4393-4404
40. Mailleux P., and Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult brain: a comparative receptor binding radioautography and in situ hybridization hystochemestry. Neuroscience 48 (1992) 655-668
41. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogrl Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
42. Mereu G., Fa M., Ferraro L., Cagiano R., Antonelli T., Tattoli M., Ghiglieri V., Tanganelli S., Gessa G.L., and Cuomo V. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl. Acad. Sci. U. S. A. 15 (2003) 4915-4920
43. Molina-Holgado F., Amaro A., Gonzalez M.I., Alvarez F.J., and Leret M.L. Effect of D9-tetrahydrocannabinol on developing serotoninergic system. Eur. J. Pharmacol. 316 (1996) 39-42
44. Moreno M., Escuredo L., Munoz R., Rodriguez de Fonseca F., and Navarro M. Long-term behavioural and neuroendocrine effects of perinatal activation or blockade of CB1 cannabinoid receptors. Behav. Pharmacology 16 (2005) 423-430
45. Murphy L.L., Steger R.W., and Bartke A. Psychoactive and non-psychoactive cannabinoids and their effects on reproductive neuroendocrine parameters. In: Watson R.R. (Ed). Biochemistry and Physiology of Substance Abuse vol. 2 (1990), CRC Press, Boca Raton 73-94
46. Navarro M., Rodriguez de Fonseca F., Hernandez M.L., Ramos J.A., and Fernandez Ruiz J.J. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 47 (1994) 47-58
47. Navarro M., de Miguel R., Rodriguez de Fonseca F., Ramos J.A., and Fernandez Ruiz J.J. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 75 (1996) 91-98
48. Richardson G.A., Ryan C., Willford J., Day N.L., and Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol. Teratol. 24 (2002) 309-320
49. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., and Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350 (1994) 240-244
50. Rodriguez de Fonseca F., Cebeira M., Fernandez Ruiz J.J., Navarro M., and Ramos J.A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 43 (1991) 713-723
51. Ronesi J., and Lovinger D.M. Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J. Physiol. 562 (2005) 245-256
52. 35S]thio)triphosphate binding in rat membranes. Life Sci. 59 (1996) 659-668
53. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
54. 9-THC) leads to changes in opiod-related behavioural patterns in rats. Brain Res. 680 (1995) 142-147
55. 9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opiod receptors in adult offspring female rats. Brain Res. 807 (1998) 101-109
56. Viveros M.P., Llorente R., Moreno E., and Marco E.M. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav. Pharmacol. 16 (2005) 353-362
57. Wang H., Dey S.K., and Maccarrone M. Jekyll and Hyde Two faces of cannabinoid signaling in male and female fertility. Endocr. Rev. 27 (2006) 427-448
58. Wang Y., Liu Y., Ito Y., Hashiguchi T., Kitajama I., Yamakuchi M., Shimizu H., Matsuo S., Imaizumi H., and Maruyama I. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymixin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 294 (2001) 73-82